Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma
Clinical trial NCT02352831 · TERMINATED
Trial details
- NCT number
- NCT02352831
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-31
- Primary completion
- 2017-10-20
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.